D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 18,606 352 World Ranking 13532 National Ranking 7007

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Her primary areas of investigation include Acquired immunodeficiency syndrome, Immunology, Pediatrics, Life expectancy and Family medicine. Her Acquired immunodeficiency syndrome research includes elements of Quality-adjusted life year, Surgery and Cost-effectiveness analysis. Her studies deal with areas such as Psychological intervention, Opportunistic infection and Disease as well as Surgery.

She interconnects Observational study, Internal medicine, Systematic review and Latent tuberculosis in the investigation of issues within Immunology. Her Life expectancy research is multidisciplinary, incorporating perspectives in Physical therapy, Cohort study, Cohort and Risk factor. Her Family medicine research integrates issues from Health care, Outpatient clinic, HIV diagnosis, Antiretroviral therapy and Psychiatry.

Her most cited work include:

  • Expanded screening for HIV in the United States--an analysis of cost-effectiveness. (493 citations)
  • The Survival Benefits of AIDS Treatment in the United States (492 citations)
  • The Survival Benefits of AIDS Treatment in the United States (492 citations)

What are the main themes of her work throughout her whole career to date?

Rochelle P. Walensky focuses on Acquired immunodeficiency syndrome, Pediatrics, Immunology, Family medicine and Internal medicine. Her Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Life expectancy, Gerontology and Public health. The study incorporates disciplines such as Cost–benefit analysis, Cohort and Cost-effectiveness analysis in addition to Life expectancy.

Her work in Pediatrics covers topics such as Developing country which are related to areas like Psychological intervention. Many of her studies on Immunology involve topics that are commonly interrelated, such as Intensive care medicine. Her Family medicine study also includes

  • Mass screening together with Test,
  • Emergency department which connect with Randomized controlled trial.

She most often published in these fields:

  • Acquired immunodeficiency syndrome (40.54%)
  • Pediatrics (24.59%)
  • Immunology (18.11%)

What were the highlights of her more recent work (between 2018-2021)?

  • Internal medicine (17.84%)
  • Coronavirus disease 2019 (4.32%)
  • Acquired immunodeficiency syndrome (40.54%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Internal medicine, Coronavirus disease 2019, Acquired immunodeficiency syndrome, Severe acute respiratory syndrome coronavirus 2 and MEDLINE. Her Internal medicine research is multidisciplinary, incorporating elements of Penicillin allergy and Antibiotics. Her studies in Coronavirus disease 2019 integrate themes in fields like Incidence, Isolation and Intensive care medicine.

Her study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Psychological intervention, Life expectancy and Regimen. The Life expectancy study combines topics in areas such as Young adult, Predictive validity, Pediatrics and Cost-effectiveness analysis. Her MEDLINE research includes themes of Cross-sectional study, Clinical trial, Health care and Family medicine.

Between 2018 and 2021, her most popular works were:

  • Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. (147 citations)
  • Scientific consensus on the COVID-19 pandemic: we need to act now. (70 citations)
  • From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle. (67 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Rochelle P. Walensky mainly focuses on Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, MEDLINE, 2019-20 coronavirus outbreak and Pandemic. Her biological study spans a wide range of topics, including Young adult, Test, Cohort and Intensive care medicine. Her Intensive care medicine research focuses on Vaccine efficacy and how it connects with Global health.

Her MEDLINE study incorporates themes from Odds ratio, Internal medicine, Logistic regression, Clinical trial and Ethnic group. Internal medicine connects with themes related to Penicillin allergy in her study. As a part of the same scientific study, she usually deals with the 2019-20 coronavirus outbreak, concentrating on Betacoronavirus and frequently concerns with Epidemiology, Infectious Disease Contact Tracing and Health policy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Survival Benefits of AIDS Treatment in the United States

Rochelle P. Walensky;Rochelle P. Walensky;A. David Paltiel;Elena Losina;Lauren M. Mercincavage.
The Journal of Infectious Diseases (2006)

707 Citations

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

A. David Paltiel;Milton C. Weinstein;April D. Kimmel;George R. Seage.
The New England Journal of Medicine (2005)

679 Citations

Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume.

Elena Losina;Rochelle P. Walensky;Courtenay L. Kessler;Parastu S. Emrani.
JAMA Internal Medicine (2009)

590 Citations

The lifetime cost of current human immunodeficiency virus care in the United States.

Bruce R. Schackman;Kelly A. Gebo;Rochelle P. Walensky;Elena Losina.
Medical Care (2006)

579 Citations

International AIDS Society global scientific strategy: towards an HIV cure 2016

Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich.
Nature Medicine (2016)

418 Citations

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.

A. David Paltiel;Amy Zheng;Rochelle P. Walensky.
JAMA Network Open (2020)

382 Citations

Review of Human Immunodeficiency Virus Type 1-Related Opportunistic Infections in Sub-Saharan Africa

Charles B. Holmes;Elena Losina;Rochelle P. Walensky;Yazdan Yazdanpanah.
Clinical Infectious Diseases (2003)

368 Citations

Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis

Jason R. Andrews;Farzad Noubary;Rochelle P. Walensky;Rodrigo Cerda.
Clinical Infectious Diseases (2012)

367 Citations

Cost-effectiveness of HIV treatment in resource-poor settings - The case of Côte d'Ivoire

Sue J. Goldie;Yazdan Yazdanpanah;Elena Losina;Milton C. Weinstein.
The New England Journal of Medicine (2006)

327 Citations

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness

A. David Paltiel;Kenneth A. Freedberg;Callie A. Scott;Bruce R. Schackman.
Clinical Infectious Diseases (2009)

304 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rochelle P. Walensky

Elena Losina

Elena Losina

Brigham and Women's Hospital

Publications: 108

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 107

Robin Wood

Robin Wood

University of Cape Town

Publications: 96

Stephen D. Lawn

Stephen D. Lawn

London School of Hygiene & Tropical Medicine

Publications: 71

Jeffrey N. Katz

Jeffrey N. Katz

Brigham and Women's Hospital

Publications: 70

Matthias Egger

Matthias Egger

University of Bern

Publications: 61

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 60

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 60

Linda-Gail Bekker

Linda-Gail Bekker

University of Cape Town

Publications: 47

Lisa R. Metsch

Lisa R. Metsch

Columbia University

Publications: 45

Till Bärnighausen

Till Bärnighausen

Heidelberg University

Publications: 44

Nathan Ford

Nathan Ford

World Health Organization

Publications: 40

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 40

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 39

David R. Bangsberg

David R. Bangsberg

VinUniversity

Publications: 38

David R. Holtgrave

David R. Holtgrave

University at Albany, State University of New York

Publications: 38

Trending Scientists

Fabio Roli

Fabio Roli

University of Genoa

Israel Cidon

Israel Cidon

VMware

Jan Vitek

Jan Vitek

Northeastern University

George S. Yip

George S. Yip

Imperial College London

Seddik Bacha

Seddik Bacha

Grenoble Alpes University

Alan Meier

Alan Meier

Lawrence Berkeley National Laboratory

Fenghua Meng

Fenghua Meng

Soochow University

Kazuhiro Imai

Kazuhiro Imai

University of Tokyo

Christoph Eckerskorn

Christoph Eckerskorn

Max Planck Society

Richard E. Michod

Richard E. Michod

University of Arizona

Xuemin Wang

Xuemin Wang

University of Missouri–St. Louis

Petra Louis

Petra Louis

University of Aberdeen

Geoffrey Blewitt

Geoffrey Blewitt

University of Nevada, Reno

Sally A. Gibson

Sally A. Gibson

University of Cambridge

Vikki M. Abrahams

Vikki M. Abrahams

Yale University

Jeffrey P. Krischer

Jeffrey P. Krischer

University of South Florida

Something went wrong. Please try again later.